In this study, we propose a novel approach designed to take advantage of the Cerenkov angular dependency to perform a direct measurement of an external beam radiation angle of incidence. The detector offers promising perspectives for external beam radiotherapy and brachytherapy applications.
This study introduces the HYPERSCINT research platform (HYPERSCINT-RP100, Medscint Inc., Quebec, Canada), the first commercially available scintillation dosimetry platform capable of multi-point dosimetry through the hyperspectral approach.
The purpose of this work is to evaluate the HYPERSCINT scintillation dosimetry research platform (Medscint Inc., Quebec City, Canada) designed for clinical QA for use in in-vivo dosimetry measurements.
Multipoint detectors are very interesting toward developing new phantoms and making measurements in constrained space. This study aims at assessing the performance of the HYPERSCINT dosimetry research platform (Medscint inc., Québec, Canada) with a high spatial resolution 3-point plastic scintillation detector for application to high energy photon beam dosimetry.
The goal of this study is to develop an approach allowing for calibration of multi-point scintillation detector (mPSD) using only the photon beam from a linear accelerator such that it doesn’t depend on the availability of other irradiation modalities (e.g. orthovoltage irradiators). This study also aims at determining an experimental method to validate the spatial position of the different scintillators within the mPSD.
This study introduces a novel hybrid Cerenkov-scintillation dosimeter
To evaluate the performance of the new Hyperscint RP200 plastic scintillator for small field measurements of a Varian TrueBeam linear accelerator in comparison with the current state-of-the-art methodology in the clinic.
This study introduces a novel hybrid detector capable of simultaneous dose and direct irradiation angle measurements based on Cerenkov angular dependency.